SNDX(Syndax Pharmaceuticals, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-29 | Podlesak Dennis | 董事 | 公开市场卖出 | 8,000 | $14.21 |
| 2026-07-08 | Metzger Michael A | Chief Executive Officer | 公开市场卖出 | 32,375 | $24.24 |
| 2026-06-12 | Botwood Nicholas A.J. | Head of R&D, CMO | 公开市场卖出 | 31,235 | $18.14 |
| 2026-06-11 | Botwood Nicholas A.J. | Head of R&D, CMO | 公开市场卖出 | 34,280 | $18.00 |
| 2026-06-01 | Goldan Keith A. | Chief Financial Officer | 公开市场卖出 | 1,177 | $18.99 |
| 2026-06-01 | Metzger Michael A | Chief Executive Officer | 公开市场卖出 | 6,847 | $18.99 |
| 2026-02-09 | Metzger Michael A | Chief Executive Officer | 公开市场卖出 | 17,159 | $21.03 |
| 2026-02-09 | Goldan Keith A. | Chief Financial Officer | 公开市场卖出 | 3,410 | $21.03 |
| 2026-02-06 | Metzger Michael A | Chief Executive Officer | 公开市场卖出 | 7,412 | $20.62 |
| 2026-02-06 | Goldan Keith A. | Chief Financial Officer | 公开市场卖出 | 2,082 | $20.62 |
| 2025-09-08 | Metzger Michael A | Chief Executive Officer | 公开市场卖出 | 157,307 | $16.41 |
| 2025-08-18 | Podlesak Dennis | 董事 | 公开市场卖出 | 19,200 | $15.84 |
| 2025-08-15 | Podlesak Dennis | 董事 | 公开市场卖出 | 19,200 | $15.54 |
| 2025-08-14 | Podlesak Dennis | 董事 | 公开市场卖出 | 19,200 | $14.19 |
| 2025-07-16 | Goldan Keith A. | Chief Financial Officer | 公开市场卖出 | 1,296 | $9.29 |
| 2025-07-16 | Metzger Michael A | Chief Executive Officer | 公开市场卖出 | 7,534 | $9.29 |
| 2025-05-19 | Goldan Keith A. | Chief Financial Officer | 公开市场买入 | 3,000 | — |
| 2025-05-19 | Huber Martin H. Jr. | 董事 | 公开市场买入 | 5,000 | $8.99 |
| 2025-05-19 | Katkin Keith | 董事 | 公开市场买入 | 10,000 | $9.11 |
| 2025-05-16 | Botwood Nicholas A.J. | Head of R&D, CMO | 公开市场买入 | 11,765 | $8.99 |